logo

SVA

Sinovac Biotech·NASDAQ
--
--(--)
--
--(--)
Latest data update time: Updated on 2026-02-07
3.96 / 10Overall Score
NeturalInvestment Rating
FundamentalSentimentTechnical
Is SVA a Buy, Sell, or Hold?
  • Based on a composite score of 3.96/10, we rate SVA as a Netural. Our analysis breaks down into 5.84/10 for Fundamentals, 5.00/10 for Technicals, and 2.50/10 for Sentiment, indicating the stock is likely to consolidate sideways.
Is SVA undervalued or overvalued?
Technical Analysis of SVA?
What is the analyst consensus for SVA?